VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 129 filers reported holding VBI VACCINES INC in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62,054 | -22.5% | 204,800 | 0.0% | 0.00% | – |
| Q4 2022 | $80,097 | -39.8% | 204,800 | +8.4% | 0.00% | – |
| Q3 2022 | $133,000 | -4.3% | 188,900 | +9.9% | 0.00% | – |
| Q2 2022 | $139,000 | -37.7% | 171,900 | +28.2% | 0.00% | – |
| Q1 2022 | $223,000 | -28.5% | 134,100 | +0.4% | 0.00% | – |
| Q4 2021 | $312,000 | -24.8% | 133,500 | 0.0% | 0.00% | – |
| Q3 2021 | $415,000 | -29.1% | 133,500 | -23.5% | 0.00% | – |
| Q2 2021 | $585,000 | +73.6% | 174,600 | +61.2% | 0.00% | – |
| Q1 2021 | $337,000 | -16.8% | 108,300 | -26.5% | 0.00% | – |
| Q4 2020 | $405,000 | -48.9% | 147,300 | -46.8% | 0.00% | – |
| Q3 2020 | $792,000 | -30.0% | 276,800 | -24.1% | 0.00% | -100.0% |
| Q2 2020 | $1,131,000 | +674.7% | 364,800 | +137.2% | 0.00% | – |
| Q1 2020 | $146,000 | +17.7% | 153,800 | +70.7% | 0.00% | – |
| Q4 2019 | $124,000 | +195.2% | 90,100 | 0.0% | 0.00% | – |
| Q3 2019 | $42,000 | -62.2% | 90,100 | -5.0% | 0.00% | – |
| Q2 2019 | $111,000 | – | 94,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.16% |
| GENERAL AMERICAN INVESTORS CO INC | 1,827,497 | $5,684,000 | 0.53% |
| Frontier Wealth Management LLC | 636,000 | $1,978,000 | 0.15% |
| Weil Company, Inc. | 56,685 | $176,000 | 0.10% |
| ArchPoint Investors | 80,000 | $249,000 | 0.07% |
| HighVista Strategies LLC | 28,600 | $89,000 | 0.07% |
| FIRST MIDWEST BANK TRUST DIVISION | 150,546 | $468,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 124,118 | $386,000 | 0.06% |
| TCI Wealth Advisors, Inc. | 30,000 | $93,000 | 0.04% |
| DCF Advisers, LLC | 26,000 | $81,000 | 0.04% |